Molecular heterogeneity analysis of poly(amidoamine) dendrimer-based mono- and multifunctional nanodevices by capillary electrophoresis
- 18 January 2006
- journal article
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 131 (3) , 374-381
- https://doi.org/10.1039/b515624f
Abstract
Poly(amidoamine) (PAMAM) dendrimer-based nanodevices are of recent interest in targeted cancer therapy. Characterization of mono- and multifunctional PAMAM-based nanodevices remains a great challenge because of their molecular complexity. In this work, various mono- and multifunctional nanodevices based on PAMAM G5 (generation 5) dendrimer were characterized by UV-Vis spectrometry, 1H NMR, size exclusion chromatography (SEC), and capillary electrophoresis (CE). CE was extensively utilized to measure the molecular heterogeneity of these PAMAM-based nanodevices. G5–FA (FA denotes folic acid) conjugates (synthesized from amine-terminated G5.NH2 dendrimer, approach 1) with acetamide and amine termini exhibit bimodal or multi-modal distributions. In contrast, G5–FA and bifunctional G5–FA–MTX (MTX denotes methotrexate) conjugates with hydroxyl termini display a single modal distribution. Multifunctional G5.Acn–FI–FA, G5.Acn–FA–OH–MTX, and G5.Acn–FI–FA–OH–MTX (Ac denotes acetamide; FI denotes fluorescein) nanodevices (synthesized from partially acetylated G5 dendrimer, approach 2) exhibit a monodisperse distribution. It indicates that the molecular distribution of PAMAM conjugates largely depends on the homogeneity of starting materials, the synthetic approaches, and the final functionalization steps. Hydroxylation functionalization of dendrimers masks the dispersity of the final PAMAM nanodevices in both synthetic approaches. The applied CE analysis of mono- and multifunctional PAMAM-based nanodevices provides a powerful tool to evaluate the molecular heterogeneity of complex dendrimer conjugate nanodevices for targeted cancer therapeutics.Keywords
This publication has 35 references indexed in Scilit:
- Poly(amidoamine) Dendrimer-Based Multifunctional Engineered Nanodevice for Cancer TherapyJournal of Medicinal Chemistry, 2005
- Targeting and Inhibition of Cell Growth by an Engineered Dendritic NanodeviceJournal of Medicinal Chemistry, 2005
- In Vitro Targeting of Synthesized Antibody-Conjugated Dendrimer NanoparticlesBiomacromolecules, 2004
- Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivativesTetrahedron, 2003
- Dendritic polymer macromolecular carriers for drug deliveryCurrent Opinion in Chemical Biology, 2002
- Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate ReceptorPharmaceutical Research, 2002
- Specific targeting of folate–dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenograftsMagnetic Resonance Materials in Physics, Biology and Medicine, 2001
- Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applicationsDrug Discovery Today, 2001
- The Synthesis and Testing of Anti-Cancer Therapeutic NanodevicesBiomedical Microdevices, 2001
- Starburst Dendrimers: Molecular‐Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic MatterAngewandte Chemie International Edition in English, 1990